Headache Disorders: New Advances in Management and Treatment Strategies: 2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 929
Special Issue Editors
Interests: headache; pain; neuromuscular disorders; epilepsy; neurooncology
Special Issues, Collections and Topics in MDPI journals
Interests: headache; migraine; pain
Special Issues, Collections and Topics in MDPI journals
Interests: headache; migraine; pain
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to the second edition of the Special Issue “Headache Disorders: New Advances in Management and Treatment Strategies: 2nd Edition” in the Journal of Clinical Medicine. The success of the first edition “Headache Disorders: New Advances in Management and Treatment Strategies” has prompted us to continue this important academic discussion with a new volume featuring both original research articles and comprehensive reviews.
Headache disorders—including migraine, cluster headache, tension-type headache, and post-traumatic headache—are among the most prevalent neurological conditions encountered in clinical practice. In recent years, significant progress has been made in understanding and treating these disorders. Notably, monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway (e.g., erenumab, fremanezumab, galcanezumab, and eptinezumab) have demonstrated efficacy in migraine prevention. Meanwhile, small-molecule CGRP receptor antagonists (gepants) and 5-HT1F receptor agonists (ditans) have expanded the options for acute treatment.
Despite these advances, a substantial number of patients continue to experience suboptimal responses, underscoring the need for more effective and personalized therapeutic strategies. Ongoing research efforts are focused on optimizing existing treatments, investigating novel targets such as PACAP inhibitors, and elucidating the complex pathophysiology of headache disorders to improve clinical outcomes.
This Special Issue seeks to highlight recent developments in the diagnosis, management, and treatment of headache disorders. We welcome submissions that offer new insights into clinical practices, novel therapeutic approaches, and the underlying biological mechanisms of these conditions. Thank you in advance for your contributions to this Special Issue. We firmly believe that your work will play a vital role in advancing knowledge and improving patient care in this important field.
Dr. Andreas A. Argyriou
Dr. Emmanouil V. Dermitzakis
Dr. Vikelis Michail
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- headache
- migraine
- cluster headache
- tension-type headache
- post-traumatic headache
- calcitonin gene-related peptide
- monoclonal antibodies
- preventive therapy
- acute treatment
- pathophysiology
- neuromodulation
- pain management
- drug development
- gepants
- ditan
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
